MedTrace Logo

Opioid Free Anesthesia and Bariatric Surgery

NCT04144153 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2024-09-19

No results posted yet for this study

Summary

The morbidly obese bariatric surgery population is susceptible to opioid-induced complications such as respiratory depression and postoperative nausea and vomiting. This population may in particular benefit from opioid-sparing or opioid-free anesthetic techniques. This study aims to evaluate the effect of opioid free total intravenous anesthesia on postoperative quality of recovery in patients undergoing bariatric surgery.

Conditions

  • Postoperative Quality of Recovery

Interventions

COMBINATION_PRODUCT

Opioid Free Total Intravenous Anesthesia

Total intravenous anesthesia with propofol and dexmedetomidine hydrochloride and ketamine hydrochloride

COMBINATION_PRODUCT

Total Intravenous anesthesia with opioid

Total Intravenous anesthesia with opioid

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Judith Aronsohn, MD · Northwell Health

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-09
Primary Completion
2023-09-01
Completion
2023-09-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04144153 on ClinicalTrials.gov